Schering-Plough Corp. faces a spate of federal court litigation over promotion of its drugs for uses not approved by the Food and Drug Administration. Eight putative class action suits are pending with U.S. District Judge Stanley Chesler in Newark, N.J., consolidated by the U.S. Judicial Panel on Multidistrict Litigation. Schering’s lawyer, Joan McPhee of Ropes & Gray, said the company will defend what it considers a free-speech right to discuss off-label uses with doctors.
Sorry, the comment form is closed at this time.